Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative betamethasone acetate 0.1% for inflammation and pain after cataract surgery
IRCT20180606039989N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betamethasone in senile cataract (ARC), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Post-operative eye inflammation and Post-operative eye pain. Started Apr 2017; status: completed.
02
Drugs
betamethasone
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on IRCT20180606039989N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180606039989N1.